Olumiant (baricitinib) - Eli Lilly
Litfulo (ritlecitinib) - Pfizer
RETRACTION: Comparative Efficacy of Janus Kinase Inhibitors Indicated for Severe Alopecia Areata: A Bayesian Network Meta-Analysis and Matching-Adjusted Indirect Comparison. (PubMed, J Dermatol) - Aug 29, 2026 - "[1] D. Aceituno, C.G. Fawsitt, G.M. Power, E. Law, S. Vaghela, and H. Thom, "Systematic review and indirect treatment comparisons of ritlecitinib against baricitinib in alopecia areata," Journal of The European Academy of Dermatology & Venereology 39, no. 6 (2025): 1134-1142, https://doi.org/10.1111/jdv.20372." 
Journal • Retrospective data • Alopecia • Dermatology • Immunology
http://www.ncbi.nlm.nih.gov/pubmed/42661279
 
Aug 29, 2026
 
Prev Next